2012 Clinician Scientist Panel

Dr. Laurence Klotz, Chair
Clinical Uro-oncologist
Chief, Division of Urology 
Sunnybrook Health Sciences Centre
Toronto, ON

Dr. Armen G. Aprikian, Co-chair
Clinical Uro-oncologist
Head Division of Urology 
McGill University Health Centre 
Montreal General Hospital
Montreal, QC

Dr. Jeremy Squire
Research Chair in Molecular Pathology, Pathology & Molecular Medicine
Professor Pathology & Molecular Medicine, Pathology & Molecular Medicine
Director NCIC Clinical Trials Group, Cancer Biology & Genetics 
Queen's University 
Kingston, ON

Dr. Himansu (Himu) Lukka
Professor, Department of Oncology
Division of Radiation Oncology 
McMaster University 
Hamilton, ON

Dr. Danny Vesprini, Science Officer
Department of Radiation Oncology 
Sunnybrook Hospital
Toronto, ON

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Click here for news archive